This inventor holds 1 USPTO granted patent. Top assignee: Faustus Forschungs Cie, Translational Cancer Research Gmbh. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: The Innovations of Stefan Schwahn
Introduction
Stefan Schwahn is a notable inventor based in Worms, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for cancer treatment. His work is characterized by a focus on innovative solutions to complex medical challenges.
Latest Patents
Stefan Schwahn holds a patent for "Indigoid bisindole derivatives." This invention relates to novel indigoid bisindole derivatives that can be utilized in the manufacture of a medicament for the treatment of solid cancers. His innovative approach aims to provide new therapeutic options for patients suffering from these challenging conditions.
Career Highlights
Stefan Schwahn is associated with Faustus Forschungs Cie, Translational Cancer Research GmbH. His role in this organization underscores his commitment to advancing cancer research and developing effective treatments. With a focus on translational research, he aims to bridge the gap between laboratory discoveries and clinical applications.
Collaborations
Stefan has collaborated with esteemed colleagues such as Doris Marko and Gerhard Eisenbrand. These partnerships enhance the research environment and foster innovation in the field of cancer therapeutics.
Conclusion
Stefan Schwahn's contributions to medicinal chemistry and cancer research exemplify the impact of innovative thinking in addressing critical health challenges. His work continues to inspire advancements in the treatment of solid cancers.